AMLX
HealthcareAmylyx Pharmaceuticals, Inc.
$13.90-0.47 (-3.30%)
Prev Close
$14.38
Open
$14.50
High
$15.01
Low
$13.78
Volume
554.5K
Market Cap
$1.17B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Amylyx Pharmaceuticals, Inc. (AMLX) has been dominated by selling, with 2 insider purchases totaling $137.8K and 36 insider sales totaling $13.33M. The most recent insider transaction was by Bedrosian Camille L (officer: Chief Medical Officer), who sold $188.4K worth of shares on Mar 4, 2026. Amylyx Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.17B.
Buys (12M)
2
$137.8K
Sells (12M)
36
$13.33M
Net Activity
Net Seller
$13.19M
Active Insiders
7
last 12 mo
AMLX Price Chart
AMLX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | Bedrosian Camille L | officer: Chief Medical Officer | Sell | 12,922 | $14.58 | $188.4K | 169,295 |
| Mar 4, 2026↗ | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 58,564 | $14.48 | $848.2K | 3,334,680 |
| Mar 4, 2026↗ | FRATES JAMES M | officer: Chief Financial Officer | Sell | 15,818 | $14.52 | $229.7K | 165,638 |
| Mar 4, 2026↗ | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 58,564 | $14.47 | $847.5K | 3,334,620 |
| Mar 4, 2026↗ | Mazzariello Gina | officer: Chief Legal Officer | Sell | 13,688 | $14.52 | $198.8K | 134,430 |
| Feb 25, 2026↗ | Mazzariello Gina | officer: Chief Legal Officer | Sell | 3,419 | $14.14 | $48.4K | 141,274 |
| Feb 4, 2026↗ | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 15,500 | $14.68 | $227.6K | 3,363,960 |
| Feb 4, 2026↗ | FRATES JAMES M | officer: Chief Financial Officer | Sell | 3,557 | $14.65 | $52.1K | 173,547 |
| Feb 4, 2026↗ | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 15,500 | $14.69 | $227.6K | 3,363,900 |
| Feb 4, 2026↗ | Mazzariello Gina | officer: Chief Legal Officer | Sell | 3,448 | $14.65 | $50.5K | 144,693 |
| Feb 2, 2026↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 15,500 | $14.68 | $227.6K | 0 |
| Feb 2, 2026↗ | FRATES JAMES M | Chief Financial Officer | Sell | 3,557 | $14.65 | $52.1K | 0 |
| Feb 2, 2026↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 15,500 | $14.69 | $227.6K | 0 |
| Feb 2, 2026↗ | Mazzariello Gina | Chief Legal Officer | Sell | 3,448 | $14.65 | $50.5K | 0 |
| Jan 20, 2026↗ | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 138,167 | $13.59 | $1.88M | 3,379,460 |
| Jan 20, 2026↗ | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 138,188 | $13.59 | $1.88M | 3,379,400 |
| Jan 15, 2026↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 138,167 | $13.59 | $1.88M | 0 |
| Jan 15, 2026↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 138,188 | $13.59 | $1.88M | 0 |
| Jan 8, 2026↗ | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 3,317,630 |
| Jan 8, 2026↗ | FRATES JAMES M | officer: Chief Financial Officer | Sell | 3,326 | $11.11 | $37.0K | 177,104 |
| Jan 8, 2026↗ | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 3,317,590 |
| Jan 6, 2026↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 0 |
| Jan 6, 2026↗ | FRATES JAMES M | Chief Financial Officer | Sell | 3,326 | $11.11 | $37.0K | 0 |
| Jan 6, 2026↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 0 |
| Dec 23, 2025↗ | Firestone Karen | Director | Buy | 8,100 | $12.45 | $100.8K | 0 |
| Dec 1, 2025↗ | Bedrosian Camille L | Chief Medical Officer | Sell | 6,580 | $14.35 | $94.4K | 0 |
| Sep 30, 2025↗ | Bedrosian Camille L | Chief Medical Officer | Sell | 12,039 | $14.58 | $175.5K | 0 |
| Sep 30, 2025↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 29,933 | $14.35 | $429.5K | 0 |
| Sep 30, 2025↗ | FRATES JAMES M | Chief Financial Officer | Sell | 10,558 | $14.65 | $154.7K | 0 |
| Sep 30, 2025↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 29,975 | $14.38 | $431.0K | 0 |
| Sep 30, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 8,828 | $14.58 | $128.7K | 0 |
| Aug 12, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 30,000 | $8.20 | $246.1K | 0 |
| Mar 31, 2025↗ | Bedrosian Camille L | Chief Medical Officer | Sell | 12,425 | $3.47 | $43.1K | 0 |
| Mar 31, 2025↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 21,490 | $3.47 | $74.5K | 0 |
| Mar 31, 2025↗ | FRATES JAMES M | Chief Financial Officer | Sell | 10,896 | $3.47 | $37.8K | 0 |
| Mar 31, 2025↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 21,490 | $3.46 | $74.5K | 0 |
| Mar 31, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 9,192 | $3.48 | $32.0K | 0 |
| Mar 20, 2025↗ | Zeiher Bernhardt G | Director | Buy | 10,000 | $3.70 | $37.0K | 0 |
| Mar 3, 2025↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 4,595 | $3.17 | $14.5K | 0 |
| Mar 3, 2025↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 4,595 | $3.15 | $14.5K | 0 |
| Mar 3, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 1,611 | $3.12 | $5.0K | 0 |
| Feb 24, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 4,169 | $3.15 | $13.1K | 0 |
| Feb 3, 2025↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 11,851 | $3.47 | $41.1K | 0 |
| Feb 3, 2025↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 11,855 | $3.47 | $41.1K | 0 |
| Feb 3, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 3,678 | $3.49 | $12.8K | 0 |
| Jan 6, 2025↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 7,471 | $4.05 | $30.2K | 0 |
| Jan 6, 2025↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 7,471 | $4.04 | $30.2K | 0 |
| Dec 2, 2024↗ | Bedrosian Camille L | Chief Medical Officer | Sell | 5,421 | $5.54 | $30.0K | 0 |
| Sep 30, 2024↗ | Bedrosian Camille L | Chief Medical Officer | Sell | 11,442 | $3.20 | $36.6K | 0 |
| Sep 30, 2024↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 18,589 | $3.20 | $59.4K | 0 |
| Sep 30, 2024↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 18,589 | $3.20 | $59.4K | 0 |
| Sep 30, 2024↗ | Mazzariello Gina | Chief Legal Officer | Sell | 8,709 | $3.20 | $27.8K | 0 |
| Sep 12, 2024↗ | FRATES JAMES M | Chief Financial Officer | Buy | 40,000 | $2.53 | $101.4K | 0 |
| Sep 5, 2024↗ | Firestone Karen | Director | Buy | 50,000 | $2.13 | $106.6K | 0 |
| Sep 3, 2024↗ | MILNE GEORGE M JR | Director | Buy | 100,000 | $2.20 | $219.8K | 0 |
| May 15, 2024↗ | Mazzariello Gina | Chief Legal Officer | Sell | 10,455 | $1.88 | $19.7K | 0 |
| May 14, 2024↗ | Quimi Daphne | Director | Buy | 5,000 | $1.89 | $9.4K | 0 |
| Mar 5, 2024↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 4,135 | $18.73 | $77.4K | 0 |
| Mar 5, 2024↗ | FRATES JAMES M | Chief Financial Officer | Sell | 1,792 | $18.73 | $33.6K | 0 |
| Mar 5, 2024↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 4,135 | $18.73 | $77.4K | 0 |
| Mar 5, 2024↗ | Mazzariello Gina | Chief Legal Officer | Sell | 1,540 | $18.73 | $28.8K | 0 |
| Feb 23, 2024↗ | Mazzariello Gina | Chief Legal Officer | Sell | 2,838 | $18.76 | $53.2K | 0 |
| Jan 9, 2024↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 5,841 | $16.33 | $95.4K | 0 |
| Jan 9, 2024↗ | FRATES JAMES M | Chief Financial Officer | Sell | 2,716 | $16.33 | $44.3K | 0 |
| Jan 9, 2024↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 5,841 | $16.33 | $95.4K | 0 |
| Jan 9, 2024↗ | Yeramian Patrick D | Chief Medical Officer | Sell | 2,812 | $16.33 | $45.9K | 0 |
| Dec 15, 2023↗ | Firestone Karen | Director | Buy | 4,000 | $14.97 | $59.9K | 0 |
| Aug 15, 2023↗ | Mazzariello Gina | Chief Legal Officer | Sell | 6,164 | $20.88 | $128.7K | 0 |
| May 16, 2023↗ | FRATES JAMES M | Chief Financial Officer | Sell | 32,500 | $26.94 | $875.5K | 0 |
| May 15, 2023↗ | Yeramian Patrick D | Chief Medical Officer | Sell | 11,965 | $29.03 | $347.4K | 0 |
| Apr 17, 2023↗ | Yeramian Patrick D | Chief Medical Officer | Sell | 49,579 | $30.54 | $1.51M | 0 |
| Mar 16, 2023↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 100,000 | $31.86 | $3.19M | 0 |
| Mar 16, 2023↗ | Firestone Karen | Director | Buy | 1,000 | $31.99 | $32.0K | 0 |
| Mar 16, 2023↗ | FRATES JAMES M | Chief Financial Officer | Sell | 32,500 | $31.89 | $1.04M | 0 |
| Mar 16, 2023↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 100,000 | $31.86 | $3.19M | 0 |
| Mar 16, 2023↗ | MILNE GEORGE M JR | Director | Sell | 35,000 | $31.89 | $1.12M | 0 |
| Mar 16, 2023↗ | Yeramian Patrick D | Chief Medical Officer | Sell | 54,627 | $31.87 | $1.74M | 0 |
| Feb 24, 2023↗ | Mazzariello Gina | Chief Legal Officer | Sell | 3,586 | $34.49 | $123.7K | 0 |
| Jan 6, 2023↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 5,968 | $36.30 | $216.6K | 0 |
| Jan 6, 2023↗ | FRATES JAMES M | Chief Financial Officer | Sell | 2,658 | $36.30 | $96.5K | 0 |
| Jan 6, 2023↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 5,968 | $36.30 | $216.6K | 0 |
| Jan 6, 2023↗ | Olinger Margaret | Chief Commercial Officer | Sell | 2,403 | $36.30 | $87.2K | 0 |
| Jan 6, 2023↗ | Yeramian Patrick D | Chief Medical Officer | Sell | 2,034 | $36.30 | $73.8K | 0 |
| Jul 6, 2022↗ | ALS Invest 1 B.V. | 10% Owner | Sell | 60,609 | $20.70 | $1.25M | 0 |
| Jan 6, 2022↗ | Cheng Isaac | Director | Buy | 6,578 | $19.00 | $125.0K | 0 |
| Jan 6, 2022↗ | FONTEYNE PAUL R. | Director | Buy | 3,947 | $19.00 | $75.0K | 0 |
| Jan 6, 2022↗ | MILNE GEORGE M JR | Director | Buy | 26,315 | $19.00 | $500.0K | 0 |
| Jan 6, 2022↗ | Olinger Margaret | Chief Commercial Officer | Buy | 6,842 | $19.00 | $130.0K | 0 |
AMLX Insider Buying Activity
The following table shows recent insider purchases of Amylyx Pharmaceuticals, Inc. (AMLX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025↗ | Firestone Karen | Director | Buy | 8,100 | $12.45 | $100.8K | 0 |
| Mar 20, 2025↗ | Zeiher Bernhardt G | Director | Buy | 10,000 | $3.70 | $37.0K | 0 |
| Sep 12, 2024↗ | FRATES JAMES M | Chief Financial Officer | Buy | 40,000 | $2.53 | $101.4K | 0 |
| Sep 5, 2024↗ | Firestone Karen | Director | Buy | 50,000 | $2.13 | $106.6K | 0 |
| Sep 3, 2024↗ | MILNE GEORGE M JR | Director | Buy | 100,000 | $2.20 | $219.8K | 0 |
| May 14, 2024↗ | Quimi Daphne | Director | Buy | 5,000 | $1.89 | $9.4K | 0 |
| Dec 15, 2023↗ | Firestone Karen | Director | Buy | 4,000 | $14.97 | $59.9K | 0 |
| Mar 16, 2023↗ | Firestone Karen | Director | Buy | 1,000 | $31.99 | $32.0K | 0 |
| Jan 6, 2022↗ | Cheng Isaac | Director | Buy | 6,578 | $19.00 | $125.0K | 0 |
| Jan 6, 2022↗ | FONTEYNE PAUL R. | Director | Buy | 3,947 | $19.00 | $75.0K | 0 |
| Jan 6, 2022↗ | MILNE GEORGE M JR | Director | Buy | 26,315 | $19.00 | $500.0K | 0 |
| Jan 6, 2022↗ | Olinger Margaret | Chief Commercial Officer | Buy | 6,842 | $19.00 | $130.0K | 0 |
AMLX Insider Selling Activity
The following table shows recent insider sales of Amylyx Pharmaceuticals, Inc. (AMLX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | Bedrosian Camille L | officer: Chief Medical Officer | Sell | 12,922 | $14.58 | $188.4K | 169,295 |
| Mar 4, 2026↗ | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 58,564 | $14.48 | $848.2K | 3,334,680 |
| Mar 4, 2026↗ | FRATES JAMES M | officer: Chief Financial Officer | Sell | 15,818 | $14.52 | $229.7K | 165,638 |
| Mar 4, 2026↗ | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 58,564 | $14.47 | $847.5K | 3,334,620 |
| Mar 4, 2026↗ | Mazzariello Gina | officer: Chief Legal Officer | Sell | 13,688 | $14.52 | $198.8K | 134,430 |
| Feb 25, 2026↗ | Mazzariello Gina | officer: Chief Legal Officer | Sell | 3,419 | $14.14 | $48.4K | 141,274 |
| Feb 4, 2026↗ | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 15,500 | $14.68 | $227.6K | 3,363,960 |
| Feb 4, 2026↗ | FRATES JAMES M | officer: Chief Financial Officer | Sell | 3,557 | $14.65 | $52.1K | 173,547 |
| Feb 4, 2026↗ | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 15,500 | $14.69 | $227.6K | 3,363,900 |
| Feb 4, 2026↗ | Mazzariello Gina | officer: Chief Legal Officer | Sell | 3,448 | $14.65 | $50.5K | 144,693 |
| Feb 2, 2026↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 15,500 | $14.68 | $227.6K | 0 |
| Feb 2, 2026↗ | FRATES JAMES M | Chief Financial Officer | Sell | 3,557 | $14.65 | $52.1K | 0 |
| Feb 2, 2026↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 15,500 | $14.69 | $227.6K | 0 |
| Feb 2, 2026↗ | Mazzariello Gina | Chief Legal Officer | Sell | 3,448 | $14.65 | $50.5K | 0 |
| Jan 20, 2026↗ | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 138,167 | $13.59 | $1.88M | 3,379,460 |
| Jan 20, 2026↗ | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 138,188 | $13.59 | $1.88M | 3,379,400 |
| Jan 15, 2026↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 138,167 | $13.59 | $1.88M | 0 |
| Jan 15, 2026↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 138,188 | $13.59 | $1.88M | 0 |
| Jan 8, 2026↗ | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 3,317,630 |
| Jan 8, 2026↗ | FRATES JAMES M | officer: Chief Financial Officer | Sell | 3,326 | $11.11 | $37.0K | 177,104 |
| Jan 8, 2026↗ | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 3,317,590 |
| Jan 6, 2026↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 0 |
| Jan 6, 2026↗ | FRATES JAMES M | Chief Financial Officer | Sell | 3,326 | $11.11 | $37.0K | 0 |
| Jan 6, 2026↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 0 |
| Dec 1, 2025↗ | Bedrosian Camille L | Chief Medical Officer | Sell | 6,580 | $14.35 | $94.4K | 0 |
| Sep 30, 2025↗ | Bedrosian Camille L | Chief Medical Officer | Sell | 12,039 | $14.58 | $175.5K | 0 |
| Sep 30, 2025↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 29,933 | $14.35 | $429.5K | 0 |
| Sep 30, 2025↗ | FRATES JAMES M | Chief Financial Officer | Sell | 10,558 | $14.65 | $154.7K | 0 |
| Sep 30, 2025↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 29,975 | $14.38 | $431.0K | 0 |
| Sep 30, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 8,828 | $14.58 | $128.7K | 0 |
| Aug 12, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 30,000 | $8.20 | $246.1K | 0 |
| Mar 31, 2025↗ | Bedrosian Camille L | Chief Medical Officer | Sell | 12,425 | $3.47 | $43.1K | 0 |
| Mar 31, 2025↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 21,490 | $3.47 | $74.5K | 0 |
| Mar 31, 2025↗ | FRATES JAMES M | Chief Financial Officer | Sell | 10,896 | $3.47 | $37.8K | 0 |
| Mar 31, 2025↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 21,490 | $3.46 | $74.5K | 0 |
| Mar 31, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 9,192 | $3.48 | $32.0K | 0 |
| Mar 3, 2025↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 4,595 | $3.17 | $14.5K | 0 |
| Mar 3, 2025↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 4,595 | $3.15 | $14.5K | 0 |
| Mar 3, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 1,611 | $3.12 | $5.0K | 0 |
| Feb 24, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 4,169 | $3.15 | $13.1K | 0 |
| Feb 3, 2025↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 11,851 | $3.47 | $41.1K | 0 |
| Feb 3, 2025↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 11,855 | $3.47 | $41.1K | 0 |
| Feb 3, 2025↗ | Mazzariello Gina | Chief Legal Officer | Sell | 3,678 | $3.49 | $12.8K | 0 |
| Jan 6, 2025↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 7,471 | $4.05 | $30.2K | 0 |
| Jan 6, 2025↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 7,471 | $4.04 | $30.2K | 0 |
| Dec 2, 2024↗ | Bedrosian Camille L | Chief Medical Officer | Sell | 5,421 | $5.54 | $30.0K | 0 |
| Sep 30, 2024↗ | Bedrosian Camille L | Chief Medical Officer | Sell | 11,442 | $3.20 | $36.6K | 0 |
| Sep 30, 2024↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 18,589 | $3.20 | $59.4K | 0 |
| Sep 30, 2024↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 18,589 | $3.20 | $59.4K | 0 |
| Sep 30, 2024↗ | Mazzariello Gina | Chief Legal Officer | Sell | 8,709 | $3.20 | $27.8K | 0 |
| May 15, 2024↗ | Mazzariello Gina | Chief Legal Officer | Sell | 10,455 | $1.88 | $19.7K | 0 |
| Mar 5, 2024↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 4,135 | $18.73 | $77.4K | 0 |
| Mar 5, 2024↗ | FRATES JAMES M | Chief Financial Officer | Sell | 1,792 | $18.73 | $33.6K | 0 |
| Mar 5, 2024↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 4,135 | $18.73 | $77.4K | 0 |
| Mar 5, 2024↗ | Mazzariello Gina | Chief Legal Officer | Sell | 1,540 | $18.73 | $28.8K | 0 |
| Feb 23, 2024↗ | Mazzariello Gina | Chief Legal Officer | Sell | 2,838 | $18.76 | $53.2K | 0 |
| Jan 9, 2024↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 5,841 | $16.33 | $95.4K | 0 |
| Jan 9, 2024↗ | FRATES JAMES M | Chief Financial Officer | Sell | 2,716 | $16.33 | $44.3K | 0 |
| Jan 9, 2024↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 5,841 | $16.33 | $95.4K | 0 |
| Jan 9, 2024↗ | Yeramian Patrick D | Chief Medical Officer | Sell | 2,812 | $16.33 | $45.9K | 0 |
| Aug 15, 2023↗ | Mazzariello Gina | Chief Legal Officer | Sell | 6,164 | $20.88 | $128.7K | 0 |
| May 16, 2023↗ | FRATES JAMES M | Chief Financial Officer | Sell | 32,500 | $26.94 | $875.5K | 0 |
| May 15, 2023↗ | Yeramian Patrick D | Chief Medical Officer | Sell | 11,965 | $29.03 | $347.4K | 0 |
| Apr 17, 2023↗ | Yeramian Patrick D | Chief Medical Officer | Sell | 49,579 | $30.54 | $1.51M | 0 |
| Mar 16, 2023↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 100,000 | $31.86 | $3.19M | 0 |
| Mar 16, 2023↗ | FRATES JAMES M | Chief Financial Officer | Sell | 32,500 | $31.89 | $1.04M | 0 |
| Mar 16, 2023↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 100,000 | $31.86 | $3.19M | 0 |
| Mar 16, 2023↗ | MILNE GEORGE M JR | Director | Sell | 35,000 | $31.89 | $1.12M | 0 |
| Mar 16, 2023↗ | Yeramian Patrick D | Chief Medical Officer | Sell | 54,627 | $31.87 | $1.74M | 0 |
| Feb 24, 2023↗ | Mazzariello Gina | Chief Legal Officer | Sell | 3,586 | $34.49 | $123.7K | 0 |
| Jan 6, 2023↗ | Cohen Joshua B | Co-Chief Executive Officer | Sell | 5,968 | $36.30 | $216.6K | 0 |
| Jan 6, 2023↗ | FRATES JAMES M | Chief Financial Officer | Sell | 2,658 | $36.30 | $96.5K | 0 |
| Jan 6, 2023↗ | Klee Justin B. | Co-Chief Executive Officer | Sell | 5,968 | $36.30 | $216.6K | 0 |
| Jan 6, 2023↗ | Olinger Margaret | Chief Commercial Officer | Sell | 2,403 | $36.30 | $87.2K | 0 |
| Jan 6, 2023↗ | Yeramian Patrick D | Chief Medical Officer | Sell | 2,034 | $36.30 | $73.8K | 0 |
| Jul 6, 2022↗ | ALS Invest 1 B.V. | 10% Owner | Sell | 60,609 | $20.70 | $1.25M | 0 |
AMLX Insiders
Similar Stocks to AMLX
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B